INSIGHTS ON DRUG DEVELOPMENT
-
Native SEC-MALS Characterization Using A Chromatography Data System
Native SEC‑MALS offers a calibration‑free way to accurately characterize peptide oligomers, helping scientists distinguish true higher‑order structures while avoiding bias.
-
Predictive Human Biology At Scale
Watch to explore applications of the Colon Intestine-Chip in studying cytokine-mediated inflammation, the effectiveness of anti-inflammatory therapies, and forthcoming immune cell recruitment.
-
Biocatalysis 101: Faster, Greener API Manufacturing
View how enzyme-driven reactions accelerate pharmaceutical ingredient manufacturing, improve selectivity, reduce waste, lower costs, and support scalable, sustainable processes under mild conditions.
-
The Complete Guide To Immunohistochemistry
Immunohistochemistry (IHC) is a tool for visualizing the distribution and localization of antigens within tissue sections. Learn about IHC sample preparation, detection and amplification systems, and more.
-
De-Risking Drug Development: Informatics-Supported Solid Form Selection5/6/2026
Learn how combining polymorph screening with structural informatics improves solid‑form selection, lowers development risk, and boosts confidence in long‑term stability and manufacturability.
-
Optimize Your RNA-LNP Delivery With Ionizable Lipids4/3/2025
Ionizable lipids play a crucial role in optimizing LNP delivery. Discover how lipid nanoparticles revolutionize intracellular drug delivery to enhance RNA vaccines, cell therapies, protein replacement, and gene editing.
-
Patient-Centric Formulations In Pediatric Adherence11/13/2025
Improving pediatric adherence requires age-appropriate formulations, taste-masking, and swallowability strategies. Regulatory, clinical, and technological insights help overcome barriers and support safer, more effective therapies for children across developmental stages.
-
From 51% Yield To 87% With Targeted Impurity Removal5/7/2026
Targeted impurity identification and purification redesign dramatically improved yield, reduced process complexity, and enabled reliable API supply for Phase II clinical development.
-
In Vivo Testing Of Nasal Dosage Forms5/7/2025
Innovative nasal drug delivery strategies can unlock faster, patient-friendly therapeutic solutions by combining smart formulation, advanced testing platforms, and rigorous preclinical evaluation.
DRUG DEVELOPMENT SOLUTIONS
-
The BioAccord™ LC-MS System with dedicated workflows for the Sartorius Ambr® 15 and small bioreactors enables process engineers to directly measure Product Quality Attributes (PQAs) and cell culture media.
-
Rapid, high-throughput IgG quantification assay. Available in 96 & 384-well microplate options.
-
Improve precision in ADME and Toxicology applications with a low-drug-absorption profile.
-
Flexible, reliable control and bioreactor systems for laboratory applications
Thermo Scientific™ HyPerforma™ bioprocess control systems are designed to optimize your process from the laboratory bench to full cGMP manufacturing. Our innovative control platform combines a flexible operating system with scalable, modular hardware, novel single-use sensors, and state-of-the-art bioreactors for strategic and streamlined bioprocess control.
HyPerforma benchtop solutions offer robust management of both cell culture and fermentation processes. The open architecture provides process flexibility, and dedicated hardware control allows for expansion. Thermo Scientific™ TruBio™ software is designed to support easy process control and scaling.
-
Backed by trusted data and deep scientific expertise, learn how our adaptive approach ensures seamless progression from preclinical development to commercial manufacturing.